Crohn's disease trials recruiting in Massachusetts

All Crohn's disease trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
  NCT04844606 · Phase: Phase 3 · Ages: 2 Years to 19 Years · Sex: All (male and female) · Massachusetts: Boston, Waltham
• A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
  NCT07219537 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Massachusetts: Boston
• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
  NCT07499232 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: New Bedford
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
  NCT05923073 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Massachusetts: Boston
• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
  NCT05509777 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Massachusetts: Boston
• A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
  NCT06581328 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Massachusetts: Framingham, New Bedford
• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
  NCT05442567 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Massachusetts: Boston
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
  NCT04779320 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Massachusetts: Boston
• A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
  NCT05995353 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Massachusetts: Waltham
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
  NCT06819891 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · Massachusetts: North Worcester
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
  NCT06819878 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · Massachusetts: Boston
• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · Massachusetts: Boston
• A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
  NCT06958536 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Massachusetts: Boston
• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
  NCT07184931 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · Massachusetts: Worcester
• Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
  NCT05781152 · Phase: Phase 4 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Massachusetts: Boston
• Cranberry and Gut Health in Crohn's Disease
  NCT07170462 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Massachusetts: Worcester
• Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
  NCT06332534 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Massachusetts: Boston
• Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis
  NCT07168499 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
  NCT06456593 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Massachusetts: New Bedford, Worcester
• Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
  NCT06655415 · Phase: Not specified · Ages: 14 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
  NCT07033208 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Massachusetts: Boston
• High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
  NCT04331639 · Phase: Not specified · Ages: 5 Years to 25 Years · Sex: All (male and female) · Massachusetts: Boston
• Low Dose IL-2 for the Treatment of Crohn's Disease
  NCT04263831 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 80 Years · Sex: All (male and female) · Massachusetts: Boston
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
  NCT06937099 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Massachusetts: New Bedford
• Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
  NCT05332639 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
  NCT04508088 · Phase: Not specified · Ages: 13 Years to 20 Years · Sex: All (male and female) · Massachusetts: Boston
• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
  NCT06548542 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Massachusetts: New Bedford
• Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
  NCT03256240 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · Massachusetts: Boston
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
  NCT06252493 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · Massachusetts: Charlestown
• Zymfentra (Infliximab-dyyb) REal World Cohort STudy
  NCT07237516 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston